Clinical Trials Directory

Trials / Completed

CompletedNCT04063397

Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia

Status
Completed
Phase
Study type
Observational
Enrollment
27 (actual)
Sponsor
Ohio State University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The investigators plan to enroll women with PE prospectively to evaluate incremental cardiovascular risk in those who have PE with severe features. This study includes detailed echocardiographic evaluation at several time points. With the current proposal, the investigators aim to collect blood to evaluate several biomarkers to determine if there is a correlation with short and medium-term cardiovascular risk. This opens the door to earlier detection, treatment and improved cardiovascular outcomes.

Detailed description

Preeclampsia (PE) is a multi-system progressive disorder affecting up to 8% of pregnancies. Epidemiologic studies have shown a significant association between PE and future cardiovascular disease (CVD) in women. Despite recognition of this relationship, there are no good markers to help determine which women are at highest risk, in particular as this relates to long-term cardiovascular risk, the number one cause of mortality in U.S. born women. As such, the study of PE and cardiovascular outcomes, in particular to identify early markers for the development of late CVD, provide insight into critical opportunities for early treatment and modification of disease trajectory in women. The investigators plan to enroll women with PE prospectively to evaluate incremental cardiovascular risk in those who have PE with severe features. This study includes detailed echocardiographic evaluation at several time points. With the current proposal, the investigators aim to collect blood to evaluate several biomarkers to determine if there is a correlation with short and medium-term cardiovascular risk. This opens the door to earlier detection, treatment and improved cardiovascular outcomes. The investigators hypothesize that preeclampsia with severe features confers a much higher risk of cardiovascular impairment compared to milder form of preeclampsia and healthy controls. If the hypothesis proves correct, these findings may change clinical practice by warranting routine echocardiogram for these patients for early recognition, intervention and treatment of cardiac dysfunction.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEchocardiogramSerial echocardiograms will be done on all patients pre-delivery, and at 3-6 months
DIAGNOSTIC_TESTBlood drawSerial blood draws at same time points as echocardiograms for biomarker levels

Timeline

Start date
2019-08-19
Primary completion
2023-01-30
Completion
2023-12-14
First posted
2019-08-21
Last updated
2024-01-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04063397. Inclusion in this directory is not an endorsement.